World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
53
Citations
18860
World Ranking
4036
National Ranking
1568

Timothy P. Sheahan publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Timothy P. Sheahan sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 167 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Timothy P. Sheahan D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Timothy P. Sheahan sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 53 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Timothy P. Sheahan is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research primarily focuses on medicine, with significant contributions in infectious diseases, epidemiology, molecular biology, immunology, and animal science and zoology.

The main topics of their work include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Respiratory viral infections research
  • Animal Virus Infections Studies
  • SARS-CoV-2 detection and testing
  • Viral gastroenteritis research and epidemiology
  • Vaccine Coverage and Hesitancy

Their recent notable publications are:

  • Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV, 2020, Nature Communications
  • An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice, 2020, Science Translational Medicine
  • A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures, 2020, Nature
  • A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice, 2020, Cell
  • Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2, 2020, Cell

Frequent co-authors include:

  • Ralph S. Baric
  • Sarah R. Leist
  • Ariane J. Brown
  • Alexandra Schäfer
  • Amy Sims

Sheahan's publications are mainly found in the following venues:

  • UNC Libraries
  • bioRxiv (Cold Spring Harbor Laboratory)
  • EClinicalMedicine
  • Science Translational Medicine
  • SSRN Electronic Journal

Their scholarly output demonstrates a focus on emerging infectious diseases, with extensive investigation into antivirals and animal models relevant to coronaviruses. The integration of molecular biology, immunology, and epidemiological study underpins their contributions to understanding and responding to viral pathogens.

Best Publications

  • Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.

    Timothy P. Sheahan;Amy C. Sims;Sarah R. Leist;Alexandra Schäfer

  • Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

    Timothy P. Sheahan;Amy C. Sims;Rachel L. Graham;Vineet D. Menachery

  • Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

    Maria L. Agostini;Erica L. Andres;Amy C Sims;Rachel Lauren Graham

  • An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.

    Timothy P. Sheahan;Amy C. Sims;Shuntai Zhou;Rachel L. Graham

  • A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.

    Kenneth H. Dinnon;Sarah R. Leist;Alexandra Schäfer;Caitlin E. Edwards

  • A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.

    Sarah R. Leist;Kenneth H. Dinnon;Alexandra Schäfer;Longping V. Tse

  • Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis

    Lisa E. Gralinski;Timothy Patrick Sheahan;Thomas E. Morrison;Vineet D. Menachery;Vineet D. Menachery

  • A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

    Unknown

  • Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase

    Ariane J. Brown;John J. Won;Rachel L. Graham;Kenneth H. Dinnon

  • Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.

    Alexandra C. Walls;Brooke Fiala;Alexandra Schäfer;Samuel Wrenn

  • Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.

    Andrea J. Pruijssers;Andrea J. Pruijssers;Amelia S. George;Amelia S. George;Alexandra Schäfer;Sarah R. Leist

  • A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice

    Anjeanette Roberts;Damon Deming;Christopher D. Paddock;Aaron Cheng

  • SARS-like WIV1-CoV poised for human emergence

    Vineet D. Menachery;Boyd L. Yount;Amy C Sims;Kari Debbink

  • Genomic Rna Elements Drive Phase Separation of the Sars-Cov-2 Nucleocapsid

    Christiane Iserman;Christine A. Roden;Mark A. Boerneke;Rachel S.G. Sealfon

  • Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies

    Zhongyu Zhu;Samitabh Chakraborti;Yuxian He;Anjeanette Roberts

  • Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo.

    Alexandra Schäfer;Frauke Muecksch;Julio C.C. Lorenzi;Sarah R. Leist

  • Mutations in the SARS-CoV-2 RNA dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms

    Unknown

  • Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice.

    Michelle M. Becker;Rachel Lauren Graham;Eric F. Donaldson;Barry Rockx

  • Small-Molecule Antiviral β-d- N 4 -Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance.

    Maria L. Agostini;Andrea J. Pruijssers;James D. Chappell;Jennifer Gribble

  • Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants

    Damon Deming;Timothy Sheahan;Mark Heise;Boyd Yount

  • β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells.

    Shuntai Zhou;Collin S Hill;Sanjay Sarkar;Longping V Tse

  • Modeling hepatitis C virus infection using human induced pluripotent stem cells

    Robert E. Schwartz;Kartik Trehan;Linda Andrus;Timothy P. Sheahan

  • Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid

    Christiane Iserman;Christine Anne Roden;Mark A. Boerneke;Rachel Sealfon

Frequent Co-Authors

Ralph S. Baric
Ralph S. Baric University of North Carolina at Chapel Hill
Amy C. Sims
Amy C. Sims University of North Carolina at Chapel Hill
Alexandra Schäfer
Alexandra Schäfer Duke University
Mark R. Denison
Mark R. Denison Vanderbilt University Medical Center
Boyd Yount
Boyd Yount University of North Carolina at Chapel Hill
Annelies Wilder-Smith
Annelies Wilder-Smith University of Bern
Tomas Cihlar
Tomas Cihlar Gilead Sciences (United States)
Charles M. Rice
Charles M. Rice Rockefeller University
David R. Martinez
David R. Martinez Yale University
Eric F. Donaldson
Eric F. Donaldson Center for Drug Evaluation and Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology in the USA opens doors not only to traditional scientific roles but also to diverse career paths in healthcare and information management. For example, professionals interested in healthcare can explore becoming a Functional Medicine Nurse Practitioner, a role combining patient care with holistic approaches. To understand compensation and career growth in this field, resources on functional medicine nurse salary offer valuable insights.

Additionally, the healthcare industry relies heavily on accurate coding and data management. Earning a professional coder certification can lead to lucrative roles that bridge clinical knowledge and administrative expertise.

For those focused on managing patient information and health data systems, a health information management degree salary overview highlights the financial and professional benefits of this career path. Pursuing one of the best cahiim accredited him programs online ensures quality education and prepares students for certification in health information management.

These pathways demonstrate the versatility of a microbiology background in the ever-evolving healthcare landscape, emphasizing education options that support both clinical and administrative career growth.

Best Scientists Citing Timothy P. Sheahan

Trending Scientists

Recently Published Articles